
1. Technology overview
Sonio is a fetal ultrasound software company headquartered in Paris, with offices in New York and Boston, and is shown on its site as a Samsung company. Its stated mission is to give access to high-quality prenatal care around the world.
The platform standardizes and automates fetal ultrasound workflows: Sonio Detect gives real-time image feedback, sorts images and checks a visual list of required views, while Sonio Suspect flags abnormal findings. Reporting fields populate automatically with built-in quality control, and the cloud-native software works with all ultrasound manufacturers and connects through DICOM, HL7 and FHIR.
2. Highlighted features & specifications
- Sonio Detect: AI-assisted exams with real-time image feedback and view checklist.
- Sonio Suspect: automatic flagging of abnormal fetal findings.
- Automated reporting: fields populate automatically with exam completeness checks.
- Image management: automated sorting and sharing, plus a patient app.
- Practice analytics: quality metrics and training plans for sonographers.
- Integrations: DICOM worklist, PACS/VNA, HL7, FHIR and CPT/ICD-10 coding.
3. Potential application
Private maternity hospitals in Vietnam can standardize second-trimester anomaly scans. Obstetric clinics can train junior sonographers with view checklists. Regional screening programs can use shared reporting and quality metrics.
4. Benefits
Real-time feedback helps operators capture complete fetal exams. Automatic report population and image sorting cut documentation time. Built-in quality control and practice analytics support training plans. Compatibility with all ultrasound brands avoids hardware lock-in.
5. Market trends & opportunities
Prenatal ultrasound quality varies widely with operator skill, which drives demand for AI that checks view completeness and flags anomalies. Vietnam's obstetric clinics and Southeast Asian private maternity chains can adopt such tools to standardize screening, subject to local regulatory approval.
6. Other information
Headquartered in Paris with US offices in New York and Boston. Owned by Samsung (acquisition approved 2024-09). Holds FDA 510(k) clearance for Sonio Detect, CE-marked AI modules, ISO 13485 and SOC 2 Type 2.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE








































